XOMA Corp.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US98419J2069
USD
31.13
1.37 (4.6%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Rigel Pharmaceuticals, Inc.
XOMA Corp.
Emergent BioSolutions, Inc.
Verrica Pharmaceuticals, Inc.
Zomedica Corp.
Fusion Pharmaceuticals, Inc.
Gossamer Bio, Inc.
Omeros Corp.
Merrimack Pharmaceuticals, Inc.
Sagimet Biosciences, Inc.
Tenaya Therapeutics, Inc.
Why is XOMA Corp. ?
1
  • OPERATING CASH FLOW(Y) Highest at USD -3.01 MM
  • PRE-TAX PROFIT(Q) At USD 2.87 MM has Grown at 174.82%
  • ROCE(HY) Highest at -12.42%
2
With ROE of -11.45%, it has a risky valuation with a 3.57 Price to Book Value
  • Over the past year, while the stock has generated a return of 2.69%, its profits have risen by 59.6%
3
High Institutional Holdings at 68.03%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to XOMA Corp. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is XOMA Corp. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
XOMA Corp.
-1.67%
0.78
47.33%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
33.68%
EBIT Growth (5y)
-169.48%
EBIT to Interest (avg)
0.06
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.24
Sales to Capital Employed (avg)
0.09
Tax Ratio
66.43%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
68.03%
ROCE (avg)
16.13%
ROE (avg)
3.99%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.57
EV to EBIT
-11.91
EV to EBITDA
-12.26
EV to Capital Employed
3.08
EV to Sales
7.51
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-25.84%
ROE (Latest)
-11.45%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

25What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -3.01 MM

PRE-TAX PROFIT(Q)

At USD 2.87 MM has Grown at 174.82%

ROCE(HY)

Highest at -12.42%

NET PROFIT(Q)

At USD 0.57 MM has Grown at 123.53%

DEBTORS TURNOVER RATIO(HY)

Highest at 2.55 times

NET SALES(Q)

At USD 13.13 MM has Grown at 22.39%

-12What is not working for the Company
NET PROFIT(HY)

At USD 4.08 MM has Grown at -47.34%

INTEREST(9M)

At USD 10.1 MM has Grown at 34.23%

RAW MATERIAL COST(Y)

Grown by 5.03% (YoY

DEBT-EQUITY RATIO (HY)

Highest at 33.14 %

Here's what is working for XOMA Corp.
Pre-Tax Profit
At USD 2.87 MM has Grown at 174.82%
over average net sales of the previous four periods of USD -3.84 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Operating Cash Flow
Highest at USD -3.01 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Profit
At USD 0.57 MM has Grown at 123.53%
over average net sales of the previous four periods of USD -2.42 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Net Sales
At USD 13.13 MM has Grown at 22.39%
over average net sales of the previous four periods of USD 10.73 MM
MOJO Watch
Near term sales trend is positive

Net Sales (USD MM)

Debtors Turnover Ratio
Highest at 2.55 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Here's what is not working for XOMA Corp.
Interest
At USD 10.1 MM has Grown at 34.23%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Debt-Equity Ratio
Highest at 33.14 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Raw Material Cost
Grown by 5.03% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales